ID: ALA123638

Max Phase: Preclinical

Molecular Formula: C14H11N3O2

Molecular Weight: 253.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1cc(Nc2cccc3ccccc23)nc(O)n1

Standard InChI:  InChI=1S/C14H11N3O2/c18-13-8-12(16-14(19)17-13)15-11-7-3-5-9-4-1-2-6-10(9)11/h1-8H,(H3,15,16,17,18,19)

Standard InChI Key:  MBZFANWCRWUDIY-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 253.26Molecular Weight (Monoisotopic): 253.0851AlogP: 2.78#Rotatable Bonds: 2
Polar Surface Area: 78.27Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.22CX Basic pKa: 0.60CX LogP: 3.74CX LogD: 3.74
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.65Np Likeness Score: -0.99

References

1. Wright GE, Brown NC..  (1980)  Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.,  23  (1): [PMID:6767030] [10.1021/jm00175a007]

Source